Cotización Alzamend Neuro - ALZN

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

1.18

Postura de Compra

1.17

Postura de Venta

1.20

Volume Operado de la Acción

637,152

1.17 Rango del Día 1.22

1.06 Rango de 52 semanas 15.06

Capitalización de Mercado [m]

6.411M

Precio Anterior

1.25

Precio de Apertura

1.201

Hora

1.1701

Última hora de negociación

11:29:30

Volumen financiero

US$ 760,290

Precio Promedio Ponderado

1.1933

Volumen promedio (3 m)

199,413

Acciones en circulación

5,432,797

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.64

Beneficio por acción (BPA)

-1.83

turnover

Beneficio neto

-9.95M

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.alzamend.com

Sede

Wilmington, Delaware, USA

Fundado

Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was US$1.25. Over the last year, Alzamend Neuro shares have traded in a share price range of US$ 1.06 to US$ 15.06.

Alzamend Neuro currently has 5,432,797 shares in issue. The market capitalisation of Alzamend Neuro is US$6.79 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.64.

Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo

Presentation Topic is the Pharmacokinetics of AL001, a Lithium Salicylate/L-Proline Co-crystal, as a Potentially Beneficial Lithium Sparing Treatment for Bipolar Disorder Type 1, Alzheimer’s...

Form 8-K - Current report

Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs

During the six months ended October 31, 2024, net cash provided by financing activities was $8.3 million Stockholder equity of $3.8 million at October 31, 2024, including $4.1 million of cash...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Alzamend Neuro Announces Full Data Set from its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimer’s Transgenic Mice

Alzamend is developing AL001, a lithium product designed for enhanced safety and efficacy compared to currently available FDA-approved and marketed lithium therapies At a low dose, AL001...

Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Data confirm the positive topline results announced in June 2023 identifying a maximum tolerated dose as assessed by an independent safety review committee Identified dose is unlikely to require...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	1.18	1.34	1.161	158333	1.23789884	CS
4	-0.12	-9.23076923077	1.3	1.36	1.06	138431	1.24159573	CS
12	-0.52	-30.5882352941	1.7	1.9	1.06	199413	1.52446203	CS
26	-3.009	-71.8309859155	4.189	15.06	1.06	923066	4.87468069	CS
52	-8.82	-88.2	10	15.06	1.06	502792	5.07758129	CS
156	-342.32	-99.6564774381	343.5	366	1.06	540744	127.56912632	CS
260	-4348.82	-99.9728735632	4350	5032.5	1.06	1128961	369.35803457	CS

ALZN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Alzamend Neuro?

El precio actual de las acciones de Alzamend Neuro es US$ 1.18

¿Cuántas acciones de Alzamend Neuro están en circulación?

Alzamend Neuro tiene 5,432,797 acciones en circulación

¿Cuál es la capitalización de mercado de Alzamend Neuro?

La capitalización de mercado de Alzamend Neuro es USD 6.79M

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Alzamend Neuro?

Alzamend Neuro ha negociado en un rango de US$ 1.06 a US$ 15.06 durante el último año

¿Cuál es el ratio PE (precio/beneficio) de Alzamend Neuro?

El ratio precio/beneficio de Alzamend Neuro es -0.64

¿Cuál es la moneda de reporte de Alzamend Neuro?

Alzamend Neuro presenta sus resultados financieros en USD

¿Cuál es el último beneficio anual de Alzamend Neuro?

El último beneficio anual de Alzamend Neuro es USD -9.95M

¿Cuál es la dirección registrada de Alzamend Neuro?

La dirección registrada de Alzamend Neuro es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

¿Cuál es la dirección del sitio web de Alzamend Neuro?

La dirección del sitio web de Alzamend Neuro es www.alzamend.com

¿En qué sector industrial opera Alzamend Neuro?

Alzamend Neuro opera en el sector PHARMACEUTICAL PREPARATIONS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MYSZMy Size Inc	US$ 5.328 (294.67%)	109.04M
EDBLEdible Garden AG Inc	US$ 0.3057 (110.25%)	91.06M
HSDTHelius Medical Technologies Inc	US$ 0.85 (77.08%)	108.27M
PRLDPrelude Therapeutics Inc	US$ 1.4383 (61.97%)	1.54M
APTOAptose Biosciences Inc	US$ 0.2685 (57.76%)	274.45M
CYNCYNGN Inc	US$ 0.401 (-75.09%)	18.79M
MTEMMolecular Templates Inc	US$ 0.1424 (-59.31%)	5.9M
GALTGalectin Therapeutics Inc	US$ 0.8783 (-56.09%)	6.4M
PRFXPainReform Ltd	US$ 4.955 (-55.60%)	2.03M
FNGRFingerMotion Inc	US$ 1.25 (-37.50%)	2.12M
APTOAptose Biosciences Inc	US$ 0.2682 (57.58%)	274.47M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.632449 (10.96%)	194.66M
RGTIRigetti Computing Inc	US$ 9.1699 (22.76%)	142.66M
TAOPTaoping Inc BVI	US$ 0.4666 (47.19%)	131.42M
NVDANVIDIA Corporation	US$ 134.795 (3.15%)	128.23M